NASDAQ / LIVE COMPANY INTELLIGENCE

Lipocine Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERLPCN
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / LPCN COVERAGE

What’s moving Lipocine Inc. now

Current reporting with the operating signal separated from the noise.

01
Lipocine Inc.: Lipocine Announces First Patient Dosed in Phase 3 Clinical Trial for LPCN 1154 in Postpartum Depression

Lipocine Inc.: Lipocine Announces First Patient Dosed in Phase 3 Clinical Trial for LPCN 1154 in Postpartum Depression

The story matters when it changes Lipocine Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
02
Lipocine Inc.

Lipocine Inc.

The story matters when it changes Lipocine Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
03
Lipocine Inc. (NASDAQ:LPCN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Lipocine Inc. (NASDAQ:LPCN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Investors are testing whether Lipocine Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
04
LPCN

SHAREHOLDER NOTICE: Scott+Scott Attorneys at Law LLP Investigates Lipocine Inc.'s Directors and Officers for Breach of Fiduciary Duties

Investors are testing whether Lipocine Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
05
Buzz Stocks: TESARO Inc, Lipocine Inc, and Energy Transfer Equity LP

Buzz Stocks: TESARO Inc, Lipocine Inc, and Energy Transfer Equity LP

Investors are testing whether Lipocine Inc.’s operating performance supports its strategy and valuation.

Watch next: deployment, backlog, capacity and segment margin.
06
Lipocine Inc. Announces Change in Trading Symbol

Lipocine Inc. Announces Change in Trading Symbol

The story matters when it changes Lipocine Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest LPCN filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-07 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-06 · Period 2025-09-30SEC ↗10-KAnnual financial reportFiled 2026-03-10 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-08-03 · Period 2026-08-03SEC ↗8-KMaterial company eventFiled 2026-06-12 · Period 2026-06-12SEC ↗8-KMaterial company eventFiled 2026-06-04 · Period 2026-06-03SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-04-21 · Period 2026-04-21SEC ↗4Official SEC filingFiled 2026-06-30 · Period 2026-06-29SEC ↗
EARNINGS / QUARTERLY TRACKER

Lipocine Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.